0.4776

4.48% -0.0224

After Hours: .48 0.0024 +0.50%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $0.4776, with a volume of 219.49K. It is down -4.48% in the last 24 hours and down -30.78% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$0.50

Open:

$0.5

24h Volume:

219.49K

Relative Volume:

1.09

Market Cap:

$15.97M

Revenue:

$7.11M

Net Income/Loss:

$-41.28M

P/E Ratio:

-0.3461

EPS:

-1.38

Net Cash Flow:

$-26.84M

1W Performance:

-7.03%

1M Performance:

-30.78%

6M Performance:

-63.54%

1Y Performance:

-59.53%

1-Day Range:

$0.45

$0.5297

1-Week Range:

$0.45

$0.6764

52-Week Range:

$0.45

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1189)

Industry

Medical Devices (159)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

155

Twitter

@Co_Diagnostics

Next Earnings Date

2024-11-07

Latest SEC Filings

CODX's Discussions on Twitter

Compare CODX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CODX Co Diagnostics Inc	0.4776	15.97M	7.11M	-41.28M	-26.84M	-1.38
ABT Abbott Laboratories	129.89	225.41B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.37	140.36B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	363.66	138.70B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.33	118.30B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	67.95	39.77B	5.72B	4.17B	259.90M	6.97

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

02:26 AM

Co-Diagnostics stock hits 52-week low at $0.45 amid market challenges - Investing.com India

02:26 AM

11:14 AM

Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Webcast - BioSpace

11:14 AM

09:30 AM

Co-Diagnostics Sets Date for Crucial Year-End 2024 Financial Results - StockTitan

09:30 AM

Mar 11, 2025

Co-Diagnostics Inc.’s Securities Class Action - Global Legal Chronicle

Mar 11, 2025

Mar 10, 2025

Co-Diagnostics Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView

Mar 10, 2025

Mar 06, 2025

Co-Diagnostics wins dismissal of class action lawsuit - TipRanks

Mar 06, 2025

Federal Court Validates Co-Diagnostics' COVID Test ClaimsWhat This Legal Win Means - StockTitan

Mar 06, 2025

Co-Diagnostics (CODX) Projected to Post Earnings on Thursday - Defense World

Mar 06, 2025

Mar 05, 2025

Analyzing ResMed (NYSE:RMD) and Co-Diagnostics (NASDAQ:CODX) - Defense World

Mar 05, 2025

Mar 03, 2025

Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges - Investing.com Australia

Mar 03, 2025

Co-Diagnostics stock hits 52-week low at $0.49 amid market challenges By Investing.com - Investing.com South Africa

Mar 03, 2025

Co-Diagnostics, Inc. and CoSara to Host HPV and Cancer Symposium on International HPV Day 2025 - PR Newswire

Mar 03, 2025

Feb 26, 2025

Comparing Globus Medical (NYSE:GMED) and Co-Diagnostics (NASDAQ:CODX) - Defense World

Feb 26, 2025

Feb 24, 2025

Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges - Investing.com Australia

Feb 24, 2025

Co-Diagnostics stock hits 52-week low at $0.65 amid market challenges By Investing.com - Investing.com South Africa

Feb 24, 2025

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version - Yahoo Finance

Feb 24, 2025

Infectious Disease Diagnostics Market (2024-2035): Trends, Growth Drivers, and Future Outlook - PharmiWeb.com

Feb 24, 2025

Looking For A Good Stock? Let This Co-Diagnostics Inc (NASDAQ: CODX) Analysis Help. - Stocks Register

Feb 24, 2025

Analyzing Co-Diagnostics (NASDAQ:CODX) and CVRx (NASDAQ:CVRX) - Defense World

Feb 24, 2025

Feb 22, 2025

CODX CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Co-Diagnostics (CODX) Investors with Significant Losses to Contact the Firm’s Attorneys, Securities Fraud Class Action Filed - ACCESS Newswire

Feb 22, 2025

Co-Dx withdraws FDA application to update COVID-19 test By Investing.com - Investing.com Australia

Feb 22, 2025

Feb 21, 2025

Co-Diagnostics Announces Intention To Submit Enhanced Version Of Covid-19 Test To FDA - Marketscreener.com

Feb 21, 2025

Co-Diagnostics Plans to Seek FDA Clearance for Enhanced Version of COVID-19 Test - Marketscreener.com

Feb 21, 2025

Co-Diagnostics Withdraws FDA Application for Covid Test -February 21, 2025 at 04:48 pm EST - Marketscreener.com

Feb 21, 2025

Co-Dx withdraws FDA application to update COVID-19 test - Investing.com India

Feb 21, 2025

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance - WV News

Feb 21, 2025

Co-Diagnostics (CODX) Stock Price, News & Analysis - MarketBeat

Feb 21, 2025

Feb 17, 2025